Author:
Seiffert Piotr,Religa Dorota
Reference46 articles.
1. Age and frailty in COVID-19 vaccine development;Andrew;Lancet (London, England),2021
2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;The New England Journal of Medicine,2021
3. SARS-CoV-2, COVID-19 and the aging immune system;Bartleson;Nature Aging,2021
4. The societal value of vaccination in the age of COVID-19;Bloom;American Journal of Public Health,2021
5. The mRNA vaccine BNT162b2 demonstrates impaired TH1 immunogenicity in human elders in vitro and aged mice in vivo;Brook;Research Square,2022